Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Antengene Presents Results of Phase 1b TOUCH Trial of Selinexor for the Treatment of T and NK-Cell Lymphoma at the 2021 American Society of Hematology (ASH) Annual Meeting 2021-12-14 18:00
CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd 2021-12-14 14:59
Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol 2021-12-14 14:00
Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea 2021-12-14 13:34
Cargene Closes a US$19.2M Pre-A Round Led by BioTrack Capital 2021-12-14 09:00
Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy 2021-12-14 08:55
Innovent Announces Pivotal Phase 2 Results for Parsaclisib (PI3Kδ inhibitor) Presented at ASH 2021 Show Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma 2021-12-14 08:00
Old Drugs Given New Life: Acura NanoMedicine Inc. Upgrades Existing Drugs Providing a More Efficient the Treatment for Cancer 2021-12-14 00:00
CARsgen Presents Updated Research Results on BCMA CAR T-cell Product (CT053) at 2021 ASH Annual Meeting 2021-12-13 20:00
Cleverin, Top Made-in-Japan Airborne Disinfectant Brand by Taiko Pharmaceutical, Accelerating Its Business Expansion in Mexico through Acquisition of Its Mexican Distributor 2021-12-13 14:00
IASO Biotherapeutics and Innovent Biologics Announced Updated Clinical Data of BCMA CAR-T Therapy in Oral Presentation at 2021 ASH Annual Meeting 2021-12-13 12:14
Phase 3 Data Demonstrate TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine Significantly Improves Event-Free Survival and Overall Survival in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia 2021-12-13 09:03
Innovent and IASO Announced Updated Clinical Data of BCMA CAR-T Therapy in Oral Presentation at 2021 ASH Annual Meeting 2021-12-13 08:00
StemiRNA Therapeutics appoints Dr. Jack Hu as Chief Financial Officer 2021-12-13 07:00
Brii Bio Announces Amubarvimab/Romlusevimab Combination Retains Neutralizing Activity Against Omicron SARS-CoV-2 Variant 2021-12-12 18:50
Phase 3 Data Show That TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine Significantly Improves Event-Free Survival and Overall Survival in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia 2021-12-12 09:00
Qiming's Portfolio Company CANbridge Pharmaceuticals Lists on Main Board of HKEx 2021-12-10 15:15
CONTROL study results show improved tolerability of NERLYNX® (neratinib) with all the investigated diarrhoea prophylaxis strategies 2021-12-10 15:11
Research shows Lianhua Qingwen capsules conferred preventive effects on those exposed to COVID-19 2021-12-10 12:49
Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan 2021-12-10 12:17
1 205 206 207 208 209 414